[go: up one dir, main page]

CY2016033I1 - Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum - Google Patents

Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum

Info

Publication number
CY2016033I1
CY2016033I1 CY2016033C CY2016033C CY2016033I1 CY 2016033 I1 CY2016033 I1 CY 2016033I1 CY 2016033 C CY2016033 C CY 2016033C CY 2016033 C CY2016033 C CY 2016033C CY 2016033 I1 CY2016033 I1 CY 2016033I1
Authority
CY
Cyprus
Prior art keywords
infantum
genes encoding
antigenic determinants
chimeric genes
protein antigenic
Prior art date
Application number
CY2016033C
Other languages
English (en)
Other versions
CY2016033I2 (el
Original Assignee
Laboratorios Leti, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA2256124A external-priority patent/CA2256124C/en
Application filed by Laboratorios Leti, S.L. filed Critical Laboratorios Leti, S.L.
Publication of CY2016033I1 publication Critical patent/CY2016033I1/el
Publication of CY2016033I2 publication Critical patent/CY2016033I2/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CY2016033C 1998-12-23 2016-10-20 Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum CY2016033I2 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11382598P 1998-12-23 1998-12-23
CA2256124A CA2256124C (en) 1998-12-23 1998-12-23 Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans
PCT/EP1999/010441 WO2000039298A1 (en) 1998-12-23 1999-12-23 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum

Publications (2)

Publication Number Publication Date
CY2016033I1 true CY2016033I1 (el) 2017-03-15
CY2016033I2 CY2016033I2 (el) 2017-03-15

Family

ID=25680668

Family Applications (3)

Application Number Title Priority Date Filing Date
CY20061101190T CY1105331T1 (el) 1998-12-23 2006-08-24 Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum
CY20091100739T CY1109221T1 (el) 1998-12-23 2009-07-14 Χιμαιρικο γονιδιο που κωδικοποιει τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum
CY2016033C CY2016033I2 (el) 1998-12-23 2016-10-20 Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CY20061101190T CY1105331T1 (el) 1998-12-23 2006-08-24 Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum
CY20091100739T CY1109221T1 (el) 1998-12-23 2009-07-14 Χιμαιρικο γονιδιο που κωδικοποιει τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum

Country Status (22)

Country Link
EP (1) EP1141305B1 (el)
CN (1) CN1158387C (el)
AT (2) ATE327332T1 (el)
AU (1) AU759316B2 (el)
BE (1) BE2016C049I2 (el)
BG (1) BG65569B1 (el)
BR (1) BRPI9916549B8 (el)
CY (3) CY1105331T1 (el)
CZ (1) CZ20012360A3 (el)
DE (2) DE69940793D1 (el)
DK (1) DK1141305T3 (el)
ES (2) ES2326174T3 (el)
HR (1) HRP20010554A2 (el)
HU (1) HUP0104743A3 (el)
IL (2) IL143956A0 (el)
LU (1) LU93259I2 (el)
MX (1) MXPA01006548A (el)
NL (1) NL300830I2 (el)
PT (2) PT1141305E (el)
SI (1) SI1624063T1 (el)
TR (1) TR200102655T2 (el)
WO (1) WO2000039298A1 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613337B1 (en) * 1997-02-12 2003-09-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
ES2169995B1 (es) * 2000-04-17 2003-12-01 Leti Lab Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno.
US6673351B1 (en) 2001-03-16 2004-01-06 Astralis, Llc Compositions and methods for the treatment and clinical remission of psoriasis
WO2006058243A2 (en) * 2004-11-24 2006-06-01 Yale University Leishmania antigens and related compositions and uses
JP2011509968A (ja) * 2008-01-18 2011-03-31 ラボラトリオス レティ、エセ.エレ.ウニペルソナル リボソームタンパク質抽出物(RPE)及び場合によってTh1促進アジュバントを含むワクチン
CN102483413A (zh) * 2009-07-13 2012-05-30 热体实验室有限公司 使用核糖体蛋白提取物(rpe)的寄生虫病如利什曼病的诊断
SA110310855B1 (ar) 2009-11-13 2014-09-16 Laboratories Leti S L Unipersonal استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي
BR102019003639A2 (pt) * 2019-02-22 2021-11-16 Fundação Oswaldo Cruz Proteína quimérica, seu método para produção e uso, bem como molécula de ácido nucleico, cassete de expressão, vetor de expressão, célula hospedeira, composição para diagnóstico de leishmaniose, kit de diagnóstico de leishmaniose e método de diagnóstico de leishmaniose in vitro
ES2795149B2 (es) 2020-06-08 2022-07-04 Univ Madrid Complutense Quimera sintetica multiepitopica como vacuna y tratamiento frente a leishmaniosis en mamiferos
CN112662694A (zh) * 2020-12-25 2021-04-16 康九生物科技(长春)有限公司 一种麦芽糖结合蛋白、麦芽糖结合蛋白表达载体、重组工程菌及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0703295A1 (en) * 1994-09-26 1996-03-27 Institut Pasteur Vaccine composition comprising recombinant BCG expressing gp 63 fusion protein
US5912166A (en) * 1995-04-21 1999-06-15 Corixa Corporation Compounds and methods for diagnosis of leishmaniasis
ES2133236B1 (es) * 1997-06-27 2000-04-16 Leti Lab Gen quimerico formado por las secuencias de dna que codifican los determinantes antigenicos de cuatro proteinas de l. infantum, aplicable para el diagnostico serologico de leishmaniosis canina y proteina obtenida.

Also Published As

Publication number Publication date
HRP20010554A2 (en) 2002-08-31
ATE429498T1 (de) 2009-05-15
WO2000039298A1 (en) 2000-07-06
BE2016C049I2 (el) 2019-03-05
CY1109221T1 (el) 2014-07-02
BG105725A (en) 2002-06-28
ES2326174T3 (es) 2009-10-02
EP1141305B1 (en) 2006-05-24
TR200102655T2 (tr) 2002-04-22
DE69931518D1 (de) 2006-06-29
ES2273519T3 (es) 2007-05-01
DK1141305T3 (da) 2006-09-25
HUP0104743A3 (en) 2004-10-28
PT1624063E (pt) 2009-06-19
NL300830I2 (nl) 2020-08-31
NL300830I1 (nl) 2016-09-28
CN1158387C (zh) 2004-07-21
PT1141305E (pt) 2006-10-31
IL143956A0 (en) 2002-04-21
MXPA01006548A (es) 2003-03-27
BG65569B1 (bg) 2008-12-30
DE69931518T2 (de) 2006-12-21
SI1624063T1 (sl) 2009-08-31
CZ20012360A3 (cs) 2001-10-17
DE69940793D1 (de) 2009-06-04
CY1105331T1 (el) 2010-03-03
AU2434200A (en) 2000-07-31
EP1141305A1 (en) 2001-10-10
BRPI9916549B1 (pt) 2018-10-02
ATE327332T1 (de) 2006-06-15
BRPI9916549B8 (pt) 2022-08-30
AU759316B2 (en) 2003-04-10
CY2016033I2 (el) 2017-03-15
BR9916549A (pt) 2005-01-04
LU93259I2 (fr) 2016-12-06
IL143956A (en) 2010-11-30
HUP0104743A2 (hu) 2002-03-28
CN1335889A (zh) 2002-02-13

Similar Documents

Publication Publication Date Title
CY2016033I2 (el) Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum
TR199902394A3 (tr) Elektrikli dis firçasi.
DE69936200D1 (de) Induktions heizgerät
EP1083926A4 (en) VACCINE
NO20032745D0 (no) Varmeanordning
DE59902598D1 (de) Allzweckreiniger mit diquaternärem polysiloxan
ES1039479Y (es) Piscina desmontable mejorada.
NO20005599L (no) Vaksine
DE60141672D1 (de) Heizvorrichtung
DE60014639D1 (de) Riechstoffe
DE69908356D1 (de) Riechstoffe
DE69903532D1 (de) 4-isobutylcyclohexanol enthaltende riechstoffe
SI1141305T1 (sl) Himerni gen, ki kodira antigenske determinante stirih proteinov L. Infantum
DK0930804T3 (da) Varmekabel
ATA27298A (de) Heizgerät
EE00294U1 (et) Veesoojendi
ATA55598A (de) Wasserheizer
IT1304521B1 (it) Bigodino.
ATA55498A (de) Wasserheizer
ATA210498A (de) Wasserheizgerät
ATA17398A (de) Wasserheizer
SE9803345D0 (sv) Kaffevärmare
ES1045945Y (es) Calefactor electrico.
ATA49898A (de) Wasserheizer
NO980940D0 (no) Varmtvannsbereder